ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

MERCEDES PINO DO

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

31,349Medicare Part D Prescriptions Filled, Including Refills

Rank: 56 out of 3647

$1.17M Total Retail Price of All Prescriptions

Rank: 149 out of 3647

758 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 758 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

3% of this provider’s 30,109 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 1,279 1,241 1 3
SIMVASTATIN 1,149 1,115 2 1
LEVOTHYROXINE SODIUM 1,061 999 3 5
RANITIDINE HCL 943 917 4 29
LISINOPRIL 876 843 5 4
ALPRAZOLAM 787 758 6 31
ATENOLOL 784 760 7 10
TEMAZEPAM 762 730 8 47
ATORVASTATIN CALCIUM 752 743 9 13
HYDROCHLOROTHIAZIDE 665 642 10 9
AMLODIPINE BESYLATE 650 638 11 2
LOVASTATIN 559 528 12 21
METOPROLOL SUCCINATE 540 530 13 18
METFORMIN HCL 525 469 14 6
CRESTOR 511 503 15 19
IBUPROFEN 509 489 16 55
LOSARTAN POTASSIUM 478 461 17 11
ALENDRONATE SODIUM 462 459 18 23
GABAPENTIN 403 379 19 17
FUROSEMIDE 401 397 20 8
NEXIUM 392 364 21 44
GLYBURIDE 377 358 R 22 54
TRAMADOL HCL 342 332 23 22
ENALAPRIL MALEATE 339 315 24 35
AMLODIPINE BESYLATE-BENAZEPRIL 329 329 25 74
LANSOPRAZOLE 304 284 26 116
PROAIR HFA 299 272 27 62
PANTOPRAZOLE SODIUM 289 281 28 38
FLUTICASONE PROPIONATE 277 257 29 32
CLOPIDOGREL 275 264 30 26
METOPROLOL TARTRATE 272 272 31 7
CILOSTAZOL 260 260 32 168
ESCITALOPRAM OXALATE 255 232 33 65
GLIPIZIDE 254 252 34 41
VESICARE 249 238 35 209
MEGESTROL ACETATE 234 234 R 36 138
PLAVIX 228 224 37 39
POTASSIUM CHLORIDE 221 221 38 24
ZOLPIDEM TARTRATE 217 205 39 14
VERAPAMIL ER 215 215 40 99
LORAZEPAM 210 196 41 73
MECLIZINE HCL 209 202 42 85
CLOTRIMAZOLE-BETAMETHASONE 196 189 43 84
CHLORDIAZEPOXIDE HCL 196 195 10 43 386
FENOFIBRATE 196 177 43 50
NAPROXEN 190 178 46 70
LOVAZA 182 155 47 117
ZETIA 180 172 48 96
ISOSORBIDE MONONITRATE ER 176 176 49 56
CARVEDILOL 176 166 49 20
PAROXETINE HCL 169 157 51 60
TRIAMTERENE-HCTZ 167 155 52 58
DIOVAN 167 158 52 40
WARFARIN SODIUM 166 152 54 15
DICLOFENAC SODIUM 164 153 55 86
TAMSULOSIN HCL 160 160 56 28
VOLTAREN 159 145 57 102
PENTOXIFYLLINE 153 153 58 180
BENICAR 150 138 59 114
RAMIPRIL 146 146 60 101
JANUVIA 146 142 60 72
LOSARTAN-HYDROCHLOROTHIAZIDE 141 141 62 48
PRAVASTATIN SODIUM 137 137 63 16
SYMBICORT 137 130 63 153
FINASTERIDE 129 129 65 66
ATENOLOL-CHLORTHALIDONE 127 127 66 171
FELODIPINE ER 125 125 67 186
VIAGRA 124 121 68 69
NIFEDIPINE ER 123 123 69 67
DIGOXIN 119 119 70 51
MUPIROCIN 117 107 71 137
METOCLOPRAMIDE HCL 114 112 72 135
DONEPEZIL HCL 113 113 73 30
SERTRALINE HCL 113 106 73 27
CITALOPRAM HBR 110 109 75 25
KETOCONAZOLE 108 104 76 132
ACTONEL 105 96 77 196
CLONIDINE HCL 103 99 78 46
TRIAMCINOLONE ACETONIDE 103 103 78 136
LISINOPRIL-HYDROCHLOROTHIAZIDE 100 100 80 36
AMITRIPTYLINE HCL 99 95 R 81 105
NITROSTAT 99 98 81 206
CLOBETASOL PROPIONATE 98 98 83 188
TERAZOSIN HCL 96 96 84 103
VYTORIN 95 91 85 191
DILTIAZEM 24HR CD 93 93 86 155
GALANTAMINE HBR 93 93 86 245
BACLOFEN 88 80 88 97
GLYBURIDE-METFORMIN HCL 88 88 R 88 94
CELEBREX 86 80 90 111
CICLOPIROX 85 80 91 176
AMMONIUM LACTATE 85 79 91 141
LEXAPRO 83 80 93 177
SYNTHROID 78 78 94 42
BENICAR HCT 78 71 94 165
ACTOS 77 77 96 148
GLIPIZIDE ER 75 74 97 112
AVAPRO 73 73 98 315
EASY TOUCH 72 61 99 279
NIFEDIAC CC 69 69 100 325
LACTULOSE 69 69 100 128
AZITHROMYCIN 68 63 102 34
NAMENDA 67 67 103 49
NYSTATIN-TRIAMCINOLONE 67 60 103 201
DIOVAN HCT 61 60 105 80
POLYETHYLENE GLYCOL 3350 61 58 105 143
VENLAFAXINE HCL ER 61 61 105 181
LIPITOR 59 59 108 113
PRANDIN 58 58 109 348
ADVAIR DISKUS 53 53 110 52
VENLAFAXINE HCL 52 52 111 272
PROCTOSOL-HC 52 52 111 480
IRBESARTAN 52 52 111 232
OXYBUTYNIN CHLORIDE 51 51 114 107
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.